We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A pathway summarising the processes pharmaceutical companies should follow when preparing to launch new products in the UK.
Helps manufacturers and healthcare professionals understand the definition of assistive technology and the difference between medical devices and aids to daily living.
The types of emissions a manufacturer or importer of e-cigarettes should notify us about.
Acceptable naming, presentation and packaging of nicotine-containing electronic cigarettes and refill containers.
Submitting annual reports on sales of electronic cigarettes and refill containers.
The VDEC clinical evaluation team works to support vaccine and therapeutic development by providing expertise in immunological and functional assays used to support clinical trials (Phase I to IV)
Information for patients, public and healthcare professionals
How the MHRA assesses marketing authorisation applications (MAA) for medicines referred under Article 29.
Guidance on applying for a Marketing Authorisation for Decentralised Manufacture, including eligibility, process, and requirements.
MHRA’s mechanism for evaluating the justifications supplied by applicant organisations who plan to utilise decentralised manufacture.
Guidance for manufacturers of artificial heart valves. It outlines specific scenarios that should be considered when determining if an incident is reportable.
Guidance for manufacturers of coronary stents. It outlines specific scenarios that should be considered when determining if an incident is reportable.
How investigators and sponsors should manage clinical trials during COVID-19
Applying for market authorisation for plasma master files (PMFs) and vaccine antigen master files (VAMFs).
VDEC works with global leaders from all sectors to develop and deliver the vaccine and therapeutic products we need to protect us from infectious diseases.
Interventions that can be made by pharmacy teams, to improve quality of life for older people.
Directions setting out the integration of the Ministry of Defence (MoD) into the NHS Prescription Service.
The Defence and Security Accelerator (DASA) is running a Market Exploration to explore research and technology development of relevance to the modelling of traumatic wounds and the monitoring of their progression.
Guidance for Marketing Authorisation (MA) applicants on providing consent to share operational information during the MA application process.
Notification Fees for Great Britain and Northern Ireland
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).